The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022
Source link
GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line
The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022
Source link
